-
#remdesivir still lacks RCT evidence to show its safety and efficacy for #Covid_19. But even more troubling is @GileadSciences history of price gauging for meds to treat diseases that hit marginalized communities hardest...like #COVID.
Unofficial archive, not affiliated with Abdul El-Sayed or X Corp. Rebuilt from a Wayback Machine capture; counts are as of that capture.